GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Ravidomycin

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act1RavidomycinStaphylococcus pyogenes (penicillin^S)BacteriaMIC (μg/ml)3.210.7164/antibiotics.36.355
act10RavidomycinKlebsiella pneumoniaeBacteriaMIC (μg/ml)2510.7164/antibiotics.36.355
act11RavidomycinSerratia marcescensBacteriaMIC (μg/ml)5010.7164/antibiotics.36.355
act12RavidomycinMycobacterium tuberculosis var. hominisBacteriaMIC (μg/ml)1~510.7164/antibiotics.36.355
act13RavidomycinPhotochromogenic mycobacteria (Group I)BacteriaMIC (μg/ml)2510.7164/antibiotics.36.355
act14RavidomycinScotochromogenic mycobacteria  (Group II)BacteriaMIC (μg/ml)510.7164/antibiotics.36.355
act15RavidomycinMycobacterium fortuitum (Group IV)BacteriaMIC (μg/ml)0.510.7164/antibiotics.36.355
act16Ravidomycinlymphocytic leukemia P388survival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}400 -10.7164/antibiotics.36.355
act17Ravidomycinlymphocytic leukemia P388survival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}200 8610.7164/antibiotics.36.355
act18Ravidomycinlymphocytic leukemia P388survival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}100 14910.7164/antibiotics.36.355
act19Ravidomycinlymphocytic leukemia P388survival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}100 23810.7164/antibiotics.36.355
act2RavidomycinStaphylococcus pyogenes (penicillin^R)BacteriaMIC (μg/ml)3.210.7164/antibiotics.36.355
act20Ravidomycinlymphocytic leukemia P388survival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}50 13610.7164/antibiotics.36.355
act21Ravidomycinlymphocytic leukemia P388survival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}25 11410.7164/antibiotics.36.355
act22RavidomycinColon 38Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}400 010.7164/antibiotics.36.355
act23RavidomycinColon 38Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}200 1310.7164/antibiotics.36.355
act24RavidomycinColon 38Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}100 3010.7164/antibiotics.36.355
act25RavidomycinColon 38Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}50 8410.7164/antibiotics.36.355
act26RavidomycinColon 38Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}25 5110.7164/antibiotics.36.355
act27RavidomycinColon 38Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}12.5 5210.7164/antibiotics.36.355
act28RavidomycinCD8F1Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}400 -10.7164/antibiotics.36.355
act29RavidomycinCD8F1Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}200 -10.7164/antibiotics.36.355
act3RavidomycinStreptococcus faecalisBacteriaMIC (μg/ml)<0.210.7164/antibiotics.36.355
act30RavidomycinCD8F1Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}100 010.7164/antibiotics.36.355
act31RavidomycinCD8F1Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}50 010.7164/antibiotics.36.355
act32RavidomycinCD8F1Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}25 5110.7164/antibiotics.36.355
act33RavidomycinCD8F1Tumor cellsurvival time of mice {Dose/injection (mg/kg)}\nsurvival time of mice {T/C (%) (MST)}12.5 7710.7164/antibiotics.36.355
act34RavidomycinP388T/C% at 400 Dose (mg/kg)19510.7164/antibiotics.36.355
act35RavidomycinP388T/C% at 200 Dose (mg/kg)20510.7164/antibiotics.36.355
act36RavidomycinP388T/C% at 100 Dose (mg/kg)17510.7164/antibiotics.36.355
act37RavidomycinP388T/C% at 50 Dose (mg/kg)14010.7164/antibiotics.36.355
act38RavidomycinP388T/C% at 25 Dose (mg/kg)15010.7164/antibiotics.36.355
act39RavidomycinP388T/C% at 12.5 Dose (mg/kg)11010.7164/antibiotics.36.355
act4RavidomycinEscherichia coliBacteriaMIC (μg/ml)10010.7164/antibiotics.36.355
act40RavidomycinP388T/C% at 6.2 Dose (mg/kg)10010.7164/antibiotics.36.355
act41RavidomycinStaphylococcus pyogenes (penicillin^S)BacteriaMIC (μg/ml)6.410.7164/antibiotics.36.355
act42RavidomycinStaphylococcus pyogenes (penicillin^R)BacteriaMIC (μg/ml)6.410.7164/antibiotics.36.355
act43RavidomycinStreptococcus faecalisBacteriaMIC (μg/ml)3.210.7164/antibiotics.36.355
act44RavidomycinEscherichia coliBacteriaMIC (μg/ml)10010.7164/antibiotics.36.355
act45RavidomycinBacillus subtilisBacteriaMIC (μg/ml)2.510.7164/antibiotics.36.355
act46RavidomycinSalmonella pullorumBacteriaMIC (μg/ml)10010.7164/antibiotics.36.355
act47RavidomycinPseudomonas aeruginosaBacteriaMIC (μg/ml)10010.7164/antibiotics.36.355
act48RavidomycinProteus mirabilisBacteriaMIC (μg/ml)10010.7164/antibiotics.36.355
act49RavidomycinProteus vulgarisBacteriaMIC (μg/ml)10010.7164/antibiotics.36.355
act5RavidomycinEnterobacter aerogenesBacteriaMIC (μg/ml)5010.7164/antibiotics.36.355
act50RavidomycinKlebsiella pneumoniaeBacteriaMIC (μg/ml)10010.7164/antibiotics.36.355
act6RavidomycinSalmonella pullorumBacteriaMIC (μg/ml)5010.7164/antibiotics.36.355
act7RavidomycinPseudomonas aeruginosaBacteriaMIC (μg/ml)5010.7164/antibiotics.36.355
act8RavidomycinProteus mirabilisBacteriaMIC (μg/ml)2510.7164/antibiotics.36.355
act9RavidomycinProteus vulgarisBacteriaMIC (μg/ml)2510.7164/antibiotics.36.355